01 1BGP Pharma Inc.
02 50BGP Pharma ULC
03 4CanReg Inc.
04 2Blank
01 21328609
02 12209714
03 22235607
04 52258606
05 92261732
06 52277274
07 12285266
08 12358395
09 52386527
10 52386534
11 52387356
12 52387361
13 12393614
14 52419729
15 52471102
01 57Clarithromycin
01 12Extended Release Tablet
02 21Film-Coated Tablets
03 22Oral Suspension
04 2Pediatric granules for suspension
01 22011-04-19
02 22016-10-18
03 12016-11-25
04 252017-07-25
05 92017-07-28
06 152017-12-19
07 22018-03-06
08 12022-07-19
Patent Expiration Date : 2016-11-25
Date Granted : 2002-07-30
Brand Name : BIAXIN XL
Patent Number : 2209714
Filing Date : 1996-11-25
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-11-25
Date Granted : 2002-07-30
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Brand Name : BIAXIN XL
Patent Number : 2386527
Filing Date : 1997-07-25
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Brand Name : BIAXIN XL
Patent Number : 2258606
Filing Date : 1997-07-25
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Patent Expiration Date : 2017-12-19
Date Granted : 2003-05-27
Brand Name : BIAXIN XL
Patent Number : 2387356
Filing Date : 1997-12-19
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-12-19
Date Granted : 2003-05-27
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Brand Name : BIAXIN XL
Patent Number : 2386534
Filing Date : 1997-07-25
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Patent Expiration Date : 2017-12-19
Date Granted : 2003-05-27
Brand Name : BIAXIN XL
Patent Number : 2387361
Filing Date : 1997-12-19
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-12-19
Date Granted : 2003-05-27
Patent Expiration Date : 2017-12-19
Date Granted : 2003-05-27
Brand Name : BIAXIN XL
Patent Number : 2277274
Filing Date : 1997-12-19
Strength per Unit : 500 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-12-19
Date Granted : 2003-05-27
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Brand Name : BIAXIN BID
Patent Number : 2386527
Filing Date : 1997-07-25
Strength per Unit : 250mg
Dosage Form : Film-Coated Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Brand Name : BIAXIN BID
Patent Number : 2258606
Filing Date : 1997-07-25
Strength per Unit : 250mg
Dosage Form : Film-Coated Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
Brand Name : BIAXIN BID
Patent Number : 2386534
Filing Date : 1997-07-25
Strength per Unit : 250mg
Dosage Form : Film-Coated Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2003-05-27
LOOKING FOR A SUPPLIER?
Market Place
